Skip to main content
SNDX logo
SNDX
(NASDAQ)
Syndax Pharmaceuticals, Inc.
$25.15-- (--)
Loading... - Market loading

Syndax Pharmaceuticals (SNDX) Stock Price & Financial Analysis

Syndax Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.21 - $25.52
52-Week High$25.59
52-Week Low$8.58
Open$23.44
Volume2.08M
Average Volume (3M)2.08M
Market Cap2.18B
Shares Outstanding86.62M
Price to Sales (P/S)12.00
Price to Book (P/B)32.01
EV/EBITDA-10.93
Revenue (TTM)172.35M
Net Income (TTM)-285.42M
Free Cash Flow (TTM)-323.17M
EPS (TTM)$-3.30
Profit Margin-165.60%
Operating Margin-158.45%
Return on Equity (ROE)-441.62%
Debt to Equity5.36
50-Day MA$21.98
200-Day MA$16.99
52-Week Change98.83%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Syndax Pharmaceuticals

What is the current stock price for SNDX?

As of the latest trading session, SNDX stock trades at $25.15. The 52-week range is $8.58–$25.59, with a day range of $23.21–$25.52.

What is the P/E ratio for SNDX?

The P/E ratio (Price-to-Earnings) for SNDX is shown in the Key Statistics section. This valuation metric helps compare Syndax Pharmaceuticals, Inc. to industry peers.

Does SNDX pay dividends?

Syndax Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SNDX?

Based on 6 analysts, the consensus for SNDX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SNDX?

Syndax Pharmaceuticals's market capitalization is $2.18B, classifying it as a mid-cap company. Syndax Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.